MétaCan
Menu
Back to cohort

Evaluation of Guideline Recommendations on Oral Medications for Type 2 Diabetes Mellitus

2012· article· en· W1976785528 on OpenAlexaboutno aff
Wendy L. Bennett, Olaide A Odelola, Lisa M Wilson, Shari Bolen, Saranya Selvaraj, Karen A. Robinson, Eric B Bass, Milo A. Puhan

Bibliographic record

VenueAnnals of Internal Medicine · 2012
Typearticle
Languageen
FieldMedicine
TopicClinical practice guidelines implementation
Canadian institutionsnot available
FundersU.S. Public Health Service
KeywordsMedicineGuidelineMEDLINECINAHLData extractionSystematic reviewDiabetes mellitusFamily medicineIntensive care medicineType 2 diabetesNursingPathologyPsychological intervention

Abstract

fetched live from OpenAlex

BACKGROUND: Clinical practice guidelines have an important role in guiding choices among the numerous medications available to treat type 2 diabetes mellitus, but little is known about their quality. PURPOSE: To assess whether guidelines on oral medications for type 2 diabetes are consistent with a systematic review of the current evidence and whether the consistency of the guidelines depends on the quality of guideline development. DATA SOURCES: MEDLINE, CINAHL, and guideline-specific databases were searched between July 2007 and August 2011, after the 2007 publication of a peer-reviewed systematic review on oral diabetes medications. STUDY SELECTION: Two reviewers independently screened citations to identify English-language guidelines on oral medications to treat type 2 diabetes that were applied in the United States, United Kingdom, and Canada. DATA EXTRACTION: Reviewers assessed whether the guidelines addressed and agreed with 7 evidence-based conclusions from the 2007 systematic review. Two reviewers independently rated guideline quality by using 2 domains from the Appraisal of Guidelines Research and Evaluation instrument. DATA SYNTHESIS: Of the 1000 screened citations, 11 guidelines met the inclusion criteria. Seven guidelines agreed with the conclusion that metformin is favored as the first-line agent. Ten guidelines agreed that thiazolidinediones are associated with higher rates of edema and congestive heart failure compared with other oral medications to treat type 2 diabetes. One guideline addressed no evidence-based conclusions, and 5 guidelines agreed with all 7 conclusions. The summary scores of the rigor of development (median, 28.6% [range, 16.7% to 100.0%]) and editorial independence (median, 75.0% [range, 8.3% to 100.0%]) domains varied greatly across guidelines. Guidelines that received higher quality scores contained more recommendations that were consistent with the evidence-based conclusions. LIMITATION: Only English-language guidelines targeting users in the United States, United Kingdom, and Canada that contained recommendations on oral medications were included. CONCLUSION: Not all practice guidelines on oral treatment of type 2 diabetes were consistent with available evidence from a systematic review. Guidelines judged to be of higher quality contained more recommendations consistent with evidence-based conclusions. The quality of guideline development processes varied substantially. PRIMARY FUNDING SOURCE: Agency for Healthcare Research and Quality.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.198
metaresearch head score (Gemma)0.608
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch
Consensus categoriesMetaresearch
DomainCandidate signal: Evaluation · Consensus signal: none
Study designCandidate signal: Systematic review · Consensus signal: Systematic review
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.802
Threshold uncertainty score0.989

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.1980.608
Meta-epidemiology (narrow)0.0020.003
Meta-epidemiology (broad)0.0100.011
Bibliometrics0.0220.019
Science and technology studies0.0020.002
Scholarly communication0.0070.006
Open science0.0090.005
Research integrity0.0070.005
Insufficient payload (model declined to judge)0.0050.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.622
GPT teacher head0.626
Teacher spread0.004 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; the direct Gemma label and the distilled Codex classifier agree on what is shown here.

Study designSystematic review
DomainEvaluation
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations86
Published2012
Admission routes1
Has abstractyes

Explore more

Same venueAnnals of Internal MedicineSame topicClinical practice guidelines implementationFrench-language works237,207